You X - Search Results

1

No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study.

Kappos L, Havrdova E, Giovannoni G, Khatri BO, Gauthier SA, Greenberg SJ, You X, Wang P, Giannattasio G. Kappos L, et al. Among authors: you x. Mult Scler. 2017 Nov;23(13):1736-1747. doi: 10.1177/1352458516683266. Epub 2016 Dec 22. Mult Scler. 2017. PMID: 28080250 Clinical Trial.

2

Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis.

Radue EW, Sprenger T, Vollmer T, Giovannoni G, Gold R, Havrdova E, Selmaj K, Stefoski D, You X, Elkins J. Radue EW, et al. Among authors: you x. Eur J Neurol. 2016 Feb;23(2):412-5. doi: 10.1111/ene.12922. Eur J Neurol. 2016. PMID: 26806217 Clinical Trial.

3

The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.

Khatri BO, Foley JF, Fink J, Kramer JF, Cha C, You X, Warth JD, Foulds P. Khatri BO, et al. Among authors: you x. Int J MS Care. 2014 Spring;16(1):40-7. doi: 10.7224/1537-2073.2013-003. Int J MS Care. 2014. PMID: 24688353 Free PMC article.

4

Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis.

Krueger JG, Kircik L, Hougeir F, Friedman A, You X, Lucas N, Greenberg SJ, Sweetser M, Castro-Borrero W, McCroskery P, Elkins J. Krueger JG, et al. Among authors: you x. Adv Ther. 2016 Jul;33(7):1231-45. doi: 10.1007/s12325-016-0353-2. Epub 2016 Jun 1. Adv Ther. 2016. PMID: 27251051 Free PMC article. Clinical Trial.

5

Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.

Bermel RA, Weinstock-Guttman B, Bourdette D, Foulds P, You X, Rudick RA. Bermel RA, et al. Among authors: you x. Mult Scler. 2010 May;16(5):588-96. doi: 10.1177/1352458509360549. Epub 2010 Feb 18. Mult Scler. 2010. PMID: 20167591 Clinical Trial.

6

Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.

Fisher E, Nakamura K, Lee JC, You X, Sperling B, Rudick RA. Fisher E, et al. Among authors: you x. Mult Scler. 2016 Apr;22(5):668-76. doi: 10.1177/1352458515599072. Epub 2015 Aug 3. Mult Scler. 2016. PMID: 26238463

7

A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.

Tolley K, Hutchinson M, You X, Wang P, Sperling B, Taneja A, Siddiqui MK, Kinter E. Tolley K, et al. Among authors: you x. PLoS One. 2015 Jun 3;10(6):e0127960. doi: 10.1371/journal.pone.0127960. eCollection 2015. PLoS One. 2015. PMID: 26039748 Free PMC article. Review.

8

Change in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: results from a trial of intramuscular interferon {beta}-1a.

Miller DM, Weinstock-Guttman B, Bourdette D, You X, Foulds P, Rudick RA. Miller DM, et al. Among authors: you x. Mult Scler. 2011 Jun;17(6):734-42. doi: 10.1177/1352458510397221. Epub 2011 Feb 7. Mult Scler. 2011. PMID: 21300736 Clinical Trial.

9

Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.

Voloshyna N, Havrdová E, Hutchinson M, Nehrych T, You X, Belachew S, Hotermans C, Paes D. Voloshyna N, et al. Among authors: you x. Eur J Neurol. 2015 Mar;22(3):570-7. doi: 10.1111/ene.12618. Epub 2014 Dec 15. Eur J Neurol. 2015. PMID: 25511792 Free PMC article.

10

Relationship between sustained disability progression and functional system scores in relapsing-remitting multiple sclerosis: analysis of placebo data from four randomized clinical trials.

Scott T, Wang P, You X, Mann M, Sperling B. Scott T, et al. Among authors: you x. Neuroepidemiology. 2015;44(1):16-23. doi: 10.1159/000369621. Epub 2015 Jan 23. Neuroepidemiology. 2015. PMID: 25634764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,732 results

Search Page

Filters